Titlebook: Drug Repurposing for Emerging Infectious Diseases and Cancer; Ranbir Chander Sobti,Sunil K. Lal,Ramesh K. Goyal Book 2023 The Editor(s) (i

只看該作者 · 發(fā)表于 2025-3-23 19:29:12

https://doi.org/10.1057/9781137349927ssential components of UPS (Ubiquitinating enzymes-E1, E2, E3, deubiquitinases, and proteasome machinery) is complex and multifaceted, and their dysregulation has been implicated in several diseases including cancer. Increasing number of studies has established UPS as a cancer therapeutic target. In

只看該作者 · 發(fā)表于 2025-3-23 22:27:16

只看該作者 · 發(fā)表于 2025-3-24 02:29:14

只看該作者 · 發(fā)表于 2025-3-24 09:03:33

只看該作者 · 發(fā)表于 2025-3-24 12:23:23

只看該作者 · 發(fā)表于 2025-3-24 16:17:06

只看該作者 · 發(fā)表于 2025-3-24 20:25:10

只看該作者 · 發(fā)表于 2025-3-25 03:12:56

Kyuil Chung,Soyoung Kim,Hyun Song Shinovery and development of new antimicrobial agents. Traditional drug discovery and development involves several stages for the discovery of a new drug and to obtain marketing approval. Drug repurposing also referred to as drug repositioning has been influential in identifying new therapeutic uses for

		自動登錄	找回密碼
密碼			To register

關于派博傳思			派博傳思旗下網站			友情鏈接
派博傳思介紹	公司地理位置	論文服務流程	影響因子官網	吾愛論文網	大講堂	北京大學	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經驗總結	SCIENCEGARD	IMPACTFACTOR	派博系數	清華大學	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-8 10:03
Copyright © 2001-2015 派博傳思京公網安備110108008328 版權所有 All rights reserved